Bioxcel Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNew Haven, CT
SAM.gov UEIKRNFT2F99W76
BioXcel Therapeutics is a company that develops pharmaceutical products using AI-based drug re-innovation. The company has products in its pipeline, including IGALMI® for agitation associated with bipolar disorders or schizophrenia, which is being evaluated in clinical trials.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Bioxcel Therapeutics, INC. | New Haven | CT | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.